These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1829666)

  • 1. Effects of V2 receptor activity on the pressor response to vasopressin in the rat.
    Shimizu K; Schwartz J; McGrath BP
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):349-52. PubMed ID: 1829666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
    Shimizu K; Schwartz J; McGrath BP
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal vasopressin modulates the reflex cardiovascular response to static contraction.
    Stebbins CL; Ortiz-Acevedo A; Hill JM
    J Appl Physiol (1985); 1992 Feb; 72(2):731-8. PubMed ID: 1532795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for vasopressin V1 receptors of rostrodiencephalic neurons: iontophoretic studies in the in vivo rat. Responses to oxytocin and to angiotensin.
    Jeulin AC; Nicolaidis S
    Brain Res Bull; 1988 Jun; 20(6):817-23. PubMed ID: 2970280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
    Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple receptor contributions to ovine fetal cardiovascular responses to vasopressin.
    Ervin MG; Terry KA; Calvario GC; Ross MG; Leake RD; Fisher DA
    Ann N Y Acad Sci; 1993 Jul; 689():504-7. PubMed ID: 8373035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E
    J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA
    Peptides; 1984; 5(3):519-22. PubMed ID: 6089144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
    Brooks VL; Hatton DC
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1878-87. PubMed ID: 1829332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.
    Noszczyk B; Lon S; Szczepańska-Sadowska E
    Brain Res; 1993 Apr; 610(1):115-26. PubMed ID: 8518919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors.
    Walker BR; Childs ME; Adams EM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H261-5. PubMed ID: 2970231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat.
    Naylor AM; Gubitz GJ; Dinarello CA; Veale WL
    Brain Res; 1987 Jan; 401(1):173-7. PubMed ID: 2949799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.